METATRACE FDG, solution for injection bottle
Active ingredients: (2R,3S,4R,5R)-2-(18F)fluoranyl-3,4,5,6-tetrahydroxyhexanal
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injectionbottleintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- METATRACE FDG, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) multidose(s) en verre de 3000 MBq/ml
- Marketing authorisation holder
- SIEMENS HEALTHCARE (ALLEMAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 27 Sept 2011
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67244392CIP75770553CIP133400957705534Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FLUDÉSOXYGLUCOSE [18F]solution | 3000 MBq · 1 ml de solution injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.